Board is reportedly split over support for GILD and PFE proposals; said to have received GILD offer that is a substantial improvement over Sanofi's rejected $52.50/shr offer - StreetInsider
- Sources say a deal with GILD might have been announced this week but some board members prefer a proposal received from PFE